uce
ProgressImage ProgressImage
Zydus Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 532321 border-img ISIN Demat INE010B01027 border-img Book Value 210.59 border-img NSE Symbol ZYDUSLIFE border-img Div & Yield % 1.16 border-img Market Cap ( Cr.) 95486.57 border-img P/E 16.61 border-img EPS 57.12 border-img Face Value 1
Quarters
ParticularsMar 2025
()
Dec 2024
()
Sep 2024
()
Gross Sales5633.502408.902512.30
Other Operating Income186.10107.00108.30
Other Income 185.4077.50326.70
Total Income6005.002593.402947.30
Total Expenditure 2046.901867.401678.40
PBIDT3958.10726.001268.90
Interest 155.4097.2095.90
PBDT3802.70628.801173.00
Depreciation128.00131.60133.70
Tax826.50-24.20248.60
Fringe Benefit Tax0.000.000.00
Deferred Tax34.5050.800.90
Reported Profit After Tax2813.70470.60789.80
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2813.70470.60789.80
    
EPS (Unit Curr.)27.964.687.85
EPS (Adj) (Unit Curr.)27.964.687.85
Calculated EPS (Unit Curr.)27.974.687.85
Calculated EPS (Adj) (Unit Curr.)27.974.687.85
Calculated EPS (Ann.) (Unit Curr.)111.8818.7131.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)111.8818.7131.40
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity100.60100.60100.60
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)70.2630.1450.51
PBDTM(%)67.5026.1046.69
PATM(%)49.9519.5431.44
x
x
×
Let's Chat
close
refresh